Aerie Pharmaceuticals Inc

MetLife Investment Management, LLC

Report date

9/30/2022

Quarter

2022 Q3

Filed

5/10/2024

Shares

24,261

Value ($000)

367

Weight

0.0%

2018 Q3 - 2022 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	5/10/2024	367	0.0%	24,261	9/30/2022
2022 Q2	5/10/2024	148	0.0%	19,670	6/30/2022
2022 Q1	5/10/2024	221	0.0%	24,266	3/31/2022
2021 Q4	5/17/2024	107	0.0%	15,265	12/31/2021
2021 Q3	5/17/2024	174	0.0%	15,265	9/30/2021
2021 Q2	5/17/2024	244	0.0%	15,265	6/30/2021
2021 Q1	5/17/2024	273	0.0%	15,265	3/31/2021
2020 Q4	5/24/2024	222	0.0%	16,438	12/31/2020
2020 Q3	5/24/2024	229	0.0%	19,440	9/30/2020
2020 Q2	5/24/2024	287	0.0%	19,440	6/30/2020
2020 Q1	7/12/2023	262	0.0%	19,440	3/31/2020
2019 Q4	7/12/2023	470	0.0%	19,440	12/31/2019
2019 Q3	7/12/2023	374	0.0%	19,440	9/30/2019
2019 Q2	7/12/2023	574	0.0%	19,440	6/30/2019
2019 Q1	7/13/2023	779	0.0%	16,392	3/31/2019
2018 Q4	7/13/2023	592	0.0%	16,392	12/31/2018
2018 Q3	7/13/2023	1,009	0.0%	16,392	9/30/2018